Mortality factors in recurrent parathyroid cancer: a pooled analysis

被引:8
作者
Tsai, Wen-Hsuan [1 ]
Zeng, Yi-Hong [1 ,2 ]
Lee, Chun-Chuan [1 ,2 ]
Tsai, Ming-Chieh [1 ,2 ]
机构
[1] Mackay Mem Hosp, Dept Endocrinol, Dept Internal Med, Div Endocrinol & Metab, 92,Sec 2,Zhongshan N Rd, Taipei 104, Taiwan
[2] MacKay Med Coll, Dept Med, New Taipei, Taiwan
关键词
Parathyroid cancer; Recurrence; Bone metastasis; Prognostic factor; PULMONARY METASTASES; TELOMERASE ACTIVITY; PROGNOSTIC-FACTORS; CARCINOMA; DIAGNOSIS; HYPERCALCEMIA; MANAGEMENT; PATIENT; PARAFIBROMIN; SURGERY;
D O I
10.1007/s00774-021-01305-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction Parathyroid cancer is a rare disease with high recurrence rate. The prognostic factors for recurrent parathyroid cancer are yet to be ascertained. We aimed to establish the association between recurrent parathyroid cancer and previously reported prognostic factors. Materials and methods We conducted a PubMed search using the keywords 'parathyroid cancer', 'parathyroid neoplasm', and 'hypercalcemia' during 1966-2019 and included 3272 articles. We focused on 73 patients with recurrent parathyroid cancer from 55 studies. We conducted a survival analysis using the Cox proportional hazards model with 95% confidence interval. Results For the 73 patients included in the analysis, the mean age (+/- standard deviation) was 44 +/- 13.2 years, wherein 36 patients were women (49.3%). During the 5236 person-months at risk (mean follow-up 71.7 months, range 3-264), 38 patients died. The incidence of local recurrence, lymph-node metastasis, lung metastasis, and bone metastasis were 60.3, 12.3, 56.2, and 24.7, respectively. Bone metastasis, disease-free interval < 1 year, and total surgeries < 3 were significant prognostic factors in univariate analysis (log-rank test P = 0.0063, P = 0.0006, and P = 0.0056, respectively). In the multivariate-adjusted analysis, the mortality risk was significantly increased in patients with bone metastasis with a hazard ratio (HR) of 4.83 (95% CI 1.16-20.2; P = 0.03), disease-free interval <=1 year of 5.92 (95% CI 1.85-18.99; P = 0.003), and total surgeries <3 of 11.29 (95% CI 2.82-45.22; P = 0.001), considering these as possible predictive prognostic factors. Conclusion Bone metastasis, duration of disease-free interval, and total number of surgeries predict survival in recurrent parathyroid cancer.
引用
收藏
页码:508 / 517
页数:10
相关论文
共 50 条
  • [41] Margin Free Resection Achieves Excellent Long Term Outcomes in Parathyroid Cancer
    Schulte, Klaus-Martin
    Talat, Nadia
    Galata, Gabriele
    [J]. CANCERS, 2023, 15 (01)
  • [42] Cohort review of patients with parathyroid cancer in End Stage Renal Disease (ESRD)
    Zheng, Victoria
    Lee, James
    Parameswaran, Rajeev
    [J]. LANGENBECKS ARCHIVES OF SURGERY, 2024, 409 (01)
  • [43] Tumor Volume Can Be Used as a Parameter Indicating the Severity of Disease in Parathyroid Cancer
    Calapkulu, Murat
    Sencar, Muhammed Erkam
    Unsal, Ilknur Ozturk
    Sakiz, Davut
    Duger, Hakan
    Ozbek, Mustafa
    Cakal, Erman
    [J]. ENDOCRINE PRACTICE, 2021, 27 (07) : 706 - 709
  • [44] Impact of multimodal therapy in locally recurrent rectal cancer
    You, Y. N.
    Skibber, J. M.
    Hu, C. -Y.
    Crane, C. H.
    Das, P.
    Kopetz, E. S.
    Eng, C.
    Feig, B. W.
    Rodriguez-Bigas, M. A.
    Chang, G. J.
    [J]. BRITISH JOURNAL OF SURGERY, 2016, 103 (06) : 753 - 762
  • [45] Pattern, Timing and Survival in Patients with Recurrent Gastric Cancer
    Cho, Jun-Min
    Fang, You-Jin
    Kim, Jong-Han
    Park, Sung-Soo
    Park, Seong-Heum
    Mok, Young-Jae
    [J]. HEPATO-GASTROENTEROLOGY, 2014, 61 (132) : 1148 - 1153
  • [46] Right Heart Thrombi: Patient Outcomes by Treatment Modality and Predictors of Mortality: A Pooled Analysis
    Islam, Marjan
    Nesheim, David
    Acquah, Samuel
    Kory, Pierre
    Kourouni, Ismini
    Ramesh, Navitha
    Ehrlich, Madeline
    Bajpayee, Gargi
    Steiger, David
    Filopei, Jason
    [J]. JOURNAL OF INTENSIVE CARE MEDICINE, 2019, 34 (11-12) : 930 - 937
  • [47] Locally recurrent colorectal cancer: results of surgical therapy
    Kruschewski, M.
    Ciurea, M.
    Lipka, S.
    Daum, S.
    Moser, L.
    Meyer, B.
    Groene, J.
    Budczies, J.
    Buhr, H. J.
    [J]. LANGENBECKS ARCHIVES OF SURGERY, 2012, 397 (07) : 1059 - 1067
  • [48] Results of a pooled analysis of IOERT containing multimodality treatment for locally recurrent rectal cancer: Results of 565 patients of two major treatment centres
    Holman, F. A.
    Bosman, S. J.
    Haddock, M. G.
    Gunderson, L. L.
    Kusters, M.
    Nieuwenhuijzen, G. A. P.
    van den Berg, H.
    Nelson, H.
    Rutten, H. J.
    [J]. EJSO, 2017, 43 (01): : 107 - 117
  • [49] Recurrent retroperitoneal sarcomas: Clinical outcomes of surgical treatment and prognostic factors
    Tropea, Saveria
    Mocellin, Simone
    Damiani, Giovanni Battista
    Stramare, Roberto
    Aliberti, Camillo
    Del Fiore, Paolo
    Rossi, Carlo Riccardo
    Rastrelli, Marco
    [J]. EJSO, 2021, 47 (05): : 1201 - 1206
  • [50] Prognostic Factors in Patients With Recurrent Pancreatic Cancer: A Multicenter Database Analysis
    Furukawa, Kenei
    Shiba, Hiroaki
    Hamura, Ryoga
    Haruki, Koichiro
    Fujiwara, Yuki
    Usuba, Teruyuki
    Nakabayashi, Yukio
    Misawa, Takeyuki
    Okamoto, Tomoyoshi
    Yanaga, Katsuhiko
    [J]. ANTICANCER RESEARCH, 2020, 40 (01) : 293 - 298